Nuchev Names Veteran Executive Matt Parker as Interim CFO

Nuchev Pty Ltd ( (AU:NUC) ) has provided an update.

Nuchev Limited has appointed Matt Parker as Interim Chief Financial Officer for six months starting 6 January 2026, bringing more than 25 years of financial and commercial leadership across FMCG, healthcare, manufacturing, retail and civil construction, including previous CFO and company secretary roles at several ASX-listed companies. The appointment signals a strengthening of Nuchev’s financial leadership as it continues to grow its nutritional and wellness portfolio across Australia, New Zealand, China and Vietnam, potentially supporting tighter financial governance and execution during a period of ongoing expansion in highly competitive consumer and practitioner-focused markets.

The most recent analyst rating on (AU:NUC) stock is a Sell with a A$0.12 price target. To see the full list of analyst forecasts on Nuchev Pty Ltd stock, see the AU:NUC Stock Forecast page.

More about Nuchev Pty Ltd

Nuchev Limited is an Australian-based nutritional and wellness company whose portfolio includes Oli6®, Bio Practica, Medicine Tree and several globally recognised European brands distributed under exclusive licence in Australia and New Zealand, primarily to practitioners as prescription-only products. Its flagship Oli6® brand is sold through key Australian pharmacy and grocery channels, online in China via cross-border e-commerce and general trade, and has recently expanded into Vietnam through offline Mother & Baby stores, other retail outlets and online platforms; Nuchev also acts as exclusive distributor for Brauer, Skin Physics and Rapid products in Australia, underpinned by a focus on high-quality ingredients and Australian manufacturing.

Average Trading Volume: 15,402

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$19.45M

See more data about NUC stock on TipRanks’ Stock Analysis page.